Relationship between the in vitro response of dendritic cells to Lactobacillus and prevention of tumorigenesis in the mouse, Journal of Gastroenterology, vol.450, issue.9, pp.661-670, 2008. ,
DOI : 10.4049/jimmunol.168.1.171
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics, Cell & Bioscience, vol.17, issue.6, p.54, 2017. ,
DOI : 10.1016/j.cmet.2013.05.004
Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility, PLoS ONE, vol.4, issue.6, 2009. ,
DOI : 10.1371/journal.pone.0006026.g007
Microbial Dysbiosis in Colorectal Cancer (CRC) Patients, PLoS ONE, vol.228, issue.1, 2011. ,
DOI : 10.1371/journal.pone.0016393.s001
URL : https://hal.archives-ouvertes.fr/hal-01190486
Towards the Human Colorectal Cancer Microbiome, PLoS ONE, vol.6, issue.1, 2011. ,
DOI : 10.1371/journal.pone.0020447.s008
URL : https://doi.org/10.1371/journal.pone.0020447
Microbiota dysbiosis is associated with colorectal cancer, Front Microbiol, 2015. ,
DOI : 10.3389/fmicb.2015.00020
URL : https://www.frontiersin.org/articles/10.3389/fmicb.2015.00020/pdf
Gut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury, Cancer Research, vol.73, issue.24, pp.7199-210, 2013. ,
DOI : 10.1158/0008-5472.CAN-13-0827
URL : http://cancerres.aacrjournals.org/content/canres/73/24/7199.full.pdf
Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice, Microbial Cell Factories, vol.6, issue.1, pp.22-32, 2007. ,
DOI : 10.1186/1475-2859-6-22
Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice, International Journal of Food Microbiology, vol.144, issue.1 ,
DOI : 10.1016/j.ijfoodmicro.2010.03.037
URL : https://hal.archives-ouvertes.fr/hal-00600679
Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice, Journal of Biotechnology, vol.151, issue.3, pp.287-93, 2011. ,
DOI : 10.1016/j.jbiotec.2010.11.008
Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer, Journal of Gastroenterology, vol.12, issue.4, pp.862-73, 2016. ,
DOI : 10.1038/ni.2002
URL : https://hal.archives-ouvertes.fr/hal-01532576
Significant differences between Lactobacillus casei subsp. casei ATCC 393T and a commonly used plasmid-cured derivative revealed by a polyphasic study, INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, vol.53, issue.1, pp.67-75, 2003. ,
DOI : 10.1099/ijs.0.02325-0
URL : http://ijs.microbiologyresearch.org/deliver/fulltext/ijsem/53/1/67.pdf?itemId=/content/journal/ijsem/10.1099/ijs.0.02325-0&mimeType=pdf&isFastTrackArticle=
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nature Medicine, vol.3, issue.6, 2016. ,
DOI : 10.1373/clinchem.2004.037465
URL : https://hal.archives-ouvertes.fr/hal-01314089
Biological and pathological activities of interleukin-22, Journal of Molecular Medicine, vol.276, issue.Suppl 1, pp.523-557, 2016. ,
DOI : 10.1074/jbc.M007837200